Community-Acquired Pneumonia

Title	Published	Price
Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies By: Venture Planning Group The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century. Among the main driving forces \| more...	11/1/2009	$25,800.00
Opportunity Analysis of H1N1 (swine flu) Vaccination Market By: MarketsandMarkets REPORT DESCRIPTION H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than more than four lac people in more than 180 countries across the globe in 2009. The \| more... Search inside this report	11/1/2009	$4,650.00
CDK Inhibitors Patent Landscape 2009 By: France Innovation Scientifique et Transfer IP Overview presents a patent landscape analysis of the CDK Inhibitor field. Alterations in CDK activity have been associated in the development of viral infections, neurodegenerative dis orders such as Alzheimer’s disease and proliferative \| more... Search inside this report	10/29/2009	$1,645.00
The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) By: Kalorama Information The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness \| more...	10/1/2009	$3,500.00
Infectious Diseases Drugs Markets By: Trimark Publications According to the World Health Organization (WHO), six infectious diseases--pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS--account for half of all premature deaths worldwide, killing mostly children and young adults. What’s more, threatening pandemics such \| more...	10/1/2009	$3,400.00
Oxygen Therapy By: Global Industry Analysts The global outlook series on Oxygen Therapy provides statistical anecdotes, market briefs, and concise summaries of research findings. The report offers an aerial view of the global oxygen therapy industry, identifies major short to medium \| more...	10/1/2009	$950.00
Respiratory and Pulmonary System Respiratory Tract Infections Therapy Area Pipeline Report By: Life Science Analytics (LSA) Life Science Analytics', Respiratory Tract Infections Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of respiratory tract infections drugs by company and by \| more... Search inside this report	9/14/2009	$1,495.00
Respiratory and Pulmonary System Pulmonary Hypertension Therapy Area Pipeline Report By: Life Science Analytics (LSA) Life Science Analytics', Pulmonary Hypertension Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of pulmonary hypertension drugs by company and by stage as \| more... Search inside this report	9/14/2009	$1,495.00
Respiratory and Pulmonary System Pulmonary Fibrosis Therapy Area Pipeline Report By: Life Science Analytics (LSA) Life Science Analytics', Pulmonary Fibrosis Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of pulmonary fibrosis drugs by company and by stage as \| more... Search inside this report	9/14/2009	$1,495.00
Respiratory and Pulmonary System Nasal congestion Therapy Area Pipeline Report By: Life Science Analytics (LSA) Life Science Analytics', Nasal congestion Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of nasal congestion drugs by company and by stage as \| more... Search inside this report	9/14/2009	$1,495.00

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 2